| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $108,387,335 ) (Continued on the next page) |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI187244 | Care, Review, Assessment and Feedback Tool In Acute Respiratory infections (CRAFT-IAR) | 000 | 2 | NIH | 2/21/2026 | $858,071 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AR080629 | Predicting risk of systemic autoimmune disease in patients with positive antinuclear antibodies | 002 | 5 | NIH | 5/14/2026 | $20,692 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AR080629 | Predicting risk of systemic autoimmune disease in patients with positive antinuclear antibodies | 001 | 5 | NIH | 2/9/2026 | $372,447 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI175245 | Technologies for High-Throughput Mapping of Antigen Specificity to B-Cell-Receptor Sequence | 000 | 4 | NIH | 5/13/2026 | $210,416 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI175245 | Technologies for High-Throughput Mapping of Antigen Specificity to B-Cell-Receptor Sequence | 000 | 4 | NIH | 5/13/2026 | $631,247 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI170172 | The role of PrEP in Getting to Zero | 000 | 3 | NIH | 4/24/2026 | $795,821 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG085873 | REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD | 000 | 3 | NIH | 2/6/2026 | $6,100,339 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG084550 | Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias | 001 | 2 | NIH | 2/23/2026 | $85,159 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG081655 | Antisocial Behavior in Frontotemporal Dementia: Behavioral Phenotypes, Neural Markers, and Decision-Making Mechanisms | 000 | 3 | NIH | 4/7/2026 | $816,857 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG084550 | Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias | 000 | 2 | NIH | 1/13/2026 | $766,423 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG085873 | REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD | 001 | 3 | NIH | 2/25/2026 | $677,817 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI093234 | Statistical Methods for Ordinal Variables in HIV/AIDS Studies | 000 | 12 | NIH | 1/7/2026 | $580,364 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI039657 | Structure and function of Helicobacter pylori VacA | 000 | 26 | NIH | 4/7/2026 | $673,106 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG098771 | Imaging Soluble Amyloid Oligomer Flow Dynamics in the Eyes for Detection of Alzheimer's Disease | 000 | 1 | NIH | 2/27/2026 | $659,026 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI101171 | Host-mediated zinc sequestration during Acinetobacter baumannii infection | 000 | 15 | NIH | 3/31/2026 | $728,458 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG092663 | Probing mechanistic links between endothelial aging and dementia | 002 | 1 | NIH | 5/5/2026 | $0 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG092663 | Probing mechanistic links between endothelial aging and dementia | 001 | 1 | NIH | 1/9/2026 | $0 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG092663 | Probing mechanistic links between endothelial aging and dementia | 000 | 1 | NIH | 12/30/2025 | $734,957 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG076785 | Common Inflammation Pathways between Aging and Hypertension That Weaken Bone | 001 | 5 | NIH | 2/25/2026 | $50,981 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG076785 | Common Inflammation Pathways between Aging and Hypertension That Weaken Bone | 000 | 5 | NIH | 1/23/2026 | $458,836 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R00HL153939 | Genomic Regulation and Translational Potential of a Novel Smooth Muscle Cell-Derived Cell Type in Atherosclerosis | 000 | 5 | NIH | 3/6/2026 | $249,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG061518 | Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease | 000 | 6 | NIH | 2/26/2026 | $1,705,551 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | P01CA116087 | H. pylori-induced Inflammation and Gastric Cancer | 000 | 19 | NIH | 3/23/2026 | $1,694,664 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 002 | 1 | NIH | 4/21/2026 | $1,500,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 001 | 1 | NIH | 12/19/2025 | $2,500,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | P30AG086403 | Vanderbilt Alzheimer's Disease Research Center | 001 | 2 | NIH | 5/4/2026 | $4,980,453 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23HL183771 | Fatty Acid Metabolic Drivers of Right Ventricular Dysfunction in Heart Failure Associated Pulmonary Hypertension | 000 | 1 | NIH | 3/26/2026 | $190,188 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23HL171904 | Advancing our Understanding of the Development, Phenotypes, and Progression of Chronic Rejection after Lung Transplantation | 001 | 3 | NIH | 3/6/2026 | $176,886 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23MH134136 | The Impact of Adversity on Neurobiological and Psychosocial Dimensions of the Stress Response System | 000 | 3 | NIH | 3/26/2026 | $185,544 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23MH140069 | Cognitive Enhancement in Recurrent Depression | 000 | 1 | NIH | 5/1/2026 | $186,624 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K24HL155891 | Mentorship in Pulmonary Vascular Disease | 000 | 5 | NIH | 2/20/2026 | $114,644 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K25AG076864 | Development and Application of T1rho Dispersion Imaging of Aging Muscle | 000 | 4 | NIH | 1/15/2026 | $75,600 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23NS131592 | Neurophysiologic Correlates of Sensory Over-Responsivity in Tourette Syndrome | 000 | 4 | NIH | 4/1/2026 | $176,772 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K24DC022692 | Mentoring in Patient-Oriented Research to Optimize Cochlear Implant Outcomes | 000 | 1 | NIH | 2/13/2026 | $136,911 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08NS140767 | Neurophysiology of Reward Signaling in Parkinson's Disease | 000 | 2 | NIH | 4/1/2026 | $190,058 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08EY032620 | Mechanisms of Photoreceptor Contribution to Retinal Inflammation in Diabetic Retinopathy | 000 | 5 | NIH | 1/9/2026 | $207,847 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08GM163052 | Immunometabolic Regulation of CD8 T Cell Dynamics in Human Critical Illness and Sepsis | 000 | 1 | NIH | 2/27/2026 | $186,224 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23DA059690 | Network-Targeted Neuromodulation for Nicotine Dependence in Schizophrenia | 000 | 3 | NIH | 2/10/2026 | $185,544 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23DA057387 | Low-dose buccal buprenorphine: Relative abuse potential and postoperative analgesic acceptability | 000 | 4 | NIH | 2/19/2026 | $172,795 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23DK136974 | Artificial Intelligence-Assisted Clinical Decision Support for Preventing Hypoglycemia in Hospitalized Patients | 000 | 3 | NIH | 3/3/2026 | $158,432 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23DK135414 | Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV | 000 | 4 | NIH | 3/3/2026 | $185,436 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23DK132513 | Understanding and Addressing Food Insecurity and Obesity Among Infant-Parent Dyads | 000 | 4 | NIH | 4/10/2026 | $176,904 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23GM150110 | Improving Prognostication for Traumatic Brain Injury | 000 | 4 | NIH | 5/7/2026 | $173,012 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23DK140531 | Optimizing an Adaptive Self-care Support Intervention for Adults with Type 2 Diabetes Leveraging their Social Relationships | 000 | 3 | NIH | 4/21/2026 | $186,624 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K01AG083223 | The role of 24-hour activity in Alzheimer's Disease | 000 | 4 | NIH | 2/26/2026 | $120,177 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08AI185260 | A Translational Bioinformatics Approach for Phenotyping and Genetic Risk of Severe Cutaneous Adverse Drug Reactions | 000 | 2 | NIH | 12/31/2025 | $186,332 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K01MD020122 | Delineating Sources of Racial, Ethnic, and Socioeconomic Differences in the Diagnosis of Generalized Anxiety Disorder | 001 | 3 | NIH | 5/7/2026 | $95,850 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08DK135931 | Understanding the physiology and pathophysiology of kidney-derived vasopressin | 000 | 4 | NIH | 3/25/2026 | $158,436 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08DA058046 | Measuring and modifying delay discounting as a mechanism of smoking in pregnancy | 000 | 3 | NIH | 2/10/2026 | $185,304 |
|
